13D Filing: Gl Partners Capital Management Ltd and Sciclone Pharmaceuticals Inc (SCLN)

Item 6 of the Schedule
13D is hereby supplemented as follows:

The descriptions in
Item 3 and Item 4 are incorporated herein by reference. The summaries of certain provisions of the agreements in this statement
on Schedule 13D are not intended to be complete and are qualified in their entirety by reference to the full text of such agreements.

To the best of the
knowledge of the Reporting Persons, except as provided herein, there are no contracts, arrangements, understandings or relationships
(legal or otherwise), including, but not limited to, transfer or voting of any of the securities, finder’s fees, joint ventures,
loan or option arrangements, puts or calls, guarantees of profits, or the giving or withholding of proxies, between any of the
Reporting Persons, and any other person, with respect to any securities of the Company, including any securities pledged or otherwise
subject to a contingency the occurrence which would give another person voting power or investment power over such securities other
than standard default and similar provisions contained in loan agreements.

Item 7 of the Schedule
13D is hereby supplemented as follows: